NRX Pharmaceuticals, Inc. (NRXP)
NCM · Common · CUSIP 629444209
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NRXP and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
629444209 (prev. 629444100 )
Market Cap
Micro Cap
Previous Symbol
BRPA (changed 5/25/2021)
Previous Name
Big Rock Partners Acquisition Corp.
Business: Big Rock Partners Acquisition Corp. is a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination. The Company intends to initially focus its search on identifying a prospective target business in the senior housing and care industry in the United States.
Notes: May 21, 2021 -- Big Rock Partners Acquisition Corp. (“Big Rock” or “BRPA”) (Nasdaq: BRPA), a publicly traded special purpose acquisition company, today confirmed that its Annual Meeting of Stockholders (the “Annual Meeting”) to consider the previously announced merger agreement with NeuroRx, Inc. (“NeuroRx” or the “Company”) will take place on May 24, 2021. Stockholders of record as of April 23, 2021 (the “Record Date”) are eligible to vote at the Annual Meeting.

Company Contact

CEO
Jonathan C. Javitt
CFO
William V. Fricker
Headquarters
1201 Orange Street, Suite 600, Wilmington, DE 19801
Phone
484-254-6134
Fax
302-298-0197
Investor Relations
Ryan Sheffield · 484-254-6134 · rsheffield@nrxpharma.com
SEC EDGAR Filings
View filings »